|
Volumn 30, Issue 2, 2013, Pages
|
"Combined" small cell and "pure" small cell lung cancer: Is there a clinical difference?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
NEURON SPECIFIC ENOLASE;
PROGASTRIN RELEASING PEPTIDE;
CANCER CHEMOTHERAPY;
CANCER CLASSIFICATION;
CANCER SURGERY;
CANCER SURVIVAL;
HISTOPATHOLOGY;
HUMAN;
LARGE CELL NEUROENDOCRINE CARCINOMA;
LETTER;
LUNG ADENOCARCINOMA;
LUNG SMALL CELL CANCER;
LUNG SQUAMOUS CELL CARCINOMA;
LUNG SURGERY;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
ADULT;
AGED;
FEMALE;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
MIDDLE AGED;
PATHOLOGY;
SURVIVAL;
VERY ELDERLY;
ADULT;
AGED;
AGED, 80 AND OVER;
CARCINOMA, NON-SMALL-CELL LUNG;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
SMALL CELL LUNG CARCINOMA;
SURVIVAL ANALYSIS;
|
EID: 84877128774
PISSN: 13570560
EISSN: 1559131X
Source Type: Journal
DOI: 10.1007/s12032-013-0600-1 Document Type: Letter |
Times cited : (5)
|
References (5)
|